Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...

Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...

The average dividend yield in the S&P 500 Index remains low at around 1.3%. As a result, many stocks have lower dividend ...

Personalized and targeted cancer therapies are showing unprecedented promise, with novel approaches potentially ...

Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

Bristol Myers Squibb has expanded its push into radiopharma by licensing a prostate cancer therapy developed by Philochem for $350m upfront.

Track all of Bristol City's 2025 summer transfer activity, including confirmed signings, player departures, latest rumours and squad updates.

U.S. News evaluates top hotels in Fort Myers using expert insights, awards, class ratings and guest reviews.

The Myers-Briggs Type Indicator is frequently used by health professions and educational programs to address the diversity of personalities that exist. No systematic review of the literature or ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the mRNA vaccine technology that was at the forefront of the world's fight ...